Cargando…
Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients
BACKGROUND: It is known that severe acute respiratory coronavirus 2 (SARS-CoV-2) is the viral strain responsible for the recent coronavirus disease 2019 (COVID-19) pandemic. Current documents have demonstrated that the virus causes a PGE2 storm in a substantial proportion of patients via upregulatin...
Autores principales: | Ghaznavi, Habib, Mohammadghasemipour, Zahra, Shirvaliloo, Milad, Momeni, Mohammad Kazem, Metanat, Malihe, Gorgani, Farzaneh, Abedipour, Fatemeh, Mohammadi, Mahdi, Sartipi, Majid, Khorashad, Ali Reza Salimi, Shahraki, Omolbanin, Ataee, Mohadese, Sheervalilou, Roghayeh, Sargazi, Saman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281238/ https://www.ncbi.nlm.nih.gov/pubmed/35834150 http://dx.doi.org/10.1007/s10787-022-01029-4 |
Ejemplares similares
-
Application of Nanobiotechnology for Early Diagnosis of SARS-CoV-2 Infection in the COVID-19 Pandemic
por: Sheervalilou, Roghayeh, et al.
Publicado: (2021) -
Chromium (III) Complexes of 4,5-diazafluoren-9-one Ligand as Potential Anti-proliferative Agents: Synthesis, Characterization, DNA Binding, Molecular Docking and In-vitro Cytotoxicity Evaluation
por: Shahraki, Omolbanin, et al.
Publicado: (2021) -
Anaphylaxis to Celebrex during an oral challenge
por: Manga, Vaishaali, et al.
Publicado: (2014) -
Association of Polymorphisms within HOX Transcript Antisense RNA (HOTAIR) with Type 2 Diabetes Mellitus and Laboratory Characteristics: A Preliminary Case-Control Study
por: Sargazi, Saman, et al.
Publicado: (2022) -
Relationship between Single Nucleotide Polymorphisms of GRHL3 and Schizophrenia Susceptibility: A Preliminary Case-Control Study and Bioinformatics Analysis
por: Sargazi, Saman, et al.
Publicado: (2020)